Further studies will be carried out to address the functional significance and clinical relevance of the 17q25.3 gain and gene over-expression in BRCA1-mutated breast cancer, such as the prediction of the response to alkylating agent or platinum-based therapy. Here, BRCA1 is linked to breast cancer.